Cerebral folate deficiency and folinic acid treatment in hypomyelination with atrophy of the basal ganglia and cerebellum (H-ABC) syndrome.
Mercimek-Mahmutoglu
Saadet
S
Stockler-Ipsiroglu
Sylvia
S
D000978:Antiparkinson Agents / Q000627:therapeutic use; D001284:Atrophy; D001479:Basal Ganglia / Q000187:drug effects* / Q000473:pathology; D001928:Brain Diseases, Metabolic / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D002230:Carbidopa / Q000627:therapeutic use; D002531:Cerebellum / Q000187:drug effects* / Q000473:pathology; D003711:Demyelinating Diseases / Q000188:drug therapy*; D004421:Dystonia / Q000188:drug therapy; D005260:Female; D005494:Folic Acid Deficiency / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use*; D007980:Levodopa / Q000627:therapeutic use; D008297:Male; D013577:Syndrome; D013763:Tetrahydrofolates / Q000134:cerebrospinal fluid; D016896:Treatment Outcome; D014803:Vitamin B Complex / Q000627:therapeutic use
D000978:Antiparkinson Agents; D013763:Tetrahydrofolates; D014803:Vitamin B Complex; D007980:Levodopa; D002230:Carbidopa; D002955:Leucovorin; C005984:5-methyltetrahydrofolate